IL1A and melanoma: Specifically, treatment of CAF isolated from melanoma patients with IL-1α/β strongly inhibited the proliferation and function of melanoma-specific cytotoxic T cells, which was attributed to an upregulation of cyclooxygenase-2 and increased surface expression of PD-L1 and PD-L2.